Kang E, Friedman N, Mamoun I, Tamburro J, Golden A. Beta Blockade as Treatment for Intracranial Infantile Hemangioma: Case Report and Literature Review.
Pediatr Neurol 2016;
59:13-7. [PMID:
27068061 DOI:
10.1016/j.pediatrneurol.2016.01.018]
[Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/06/2015] [Revised: 01/20/2016] [Accepted: 01/22/2016] [Indexed: 11/29/2022]
Abstract
BACKGROUND
Intracranial infantile hemangiomas are extremely rare, with only 36 patients reported in literature. Treatment for intracranial infantile hemangiomas has been mostly limited to surgery, steroids, and interferon therapy. Propranolol, which is often used to treat cutaneous infantile hemangiomas, is not currently standard treatment for intracranial infantile hemangiomas.
PATIENT DESCRIPTION
We present a one-month old boy with an intracranial infantile hemangioma treated with propranolol.
RESULTS
This boy was being treated with oral propranolol for a supraclavicular infantile hemangioma. Subsequent brain magnetic resonance imaging (MRI) scan showed evidence of an associated intracranial infantile hemangioma in the right cerebellopontine angle. Repeat brain MRI scan after two months of propranolol treatment demonstrated a significant reduction in the size of the intracranial infantile hemangioma.
CONCLUSIONS
This is the first report of successful therapy of an intracranial infantile hemangioma with propranolol.
Collapse